Oriflame har emitterat obligationslån om 165 miljoner USD i private
placement-marknaden. Oriflame har valt att använda sig av private
placement-marknaden i syfte att bredda sin finansiering. Transaktionen blev
mycket väl mottagen bland investerarna och blev övertecknad nära två gånger.
Obligationslånen förfaller 2015, 2017 respektive 2020.
"Detta är ett led i vår strategi att diversifiera Oriflames finansieringskällor
utöver våra banklån samt att uppnå en längre snittlöptid i vår låneportfölj",
kommenterar Gabriel Bennet, finansdirektör.
The Royal Bank of Scotland var Agent i samband med transaktionen och var även
rådgivare avseende valuta- och räntesäkringsstrategin då finansieringen
swappades till EUR.
För ytterligare information, kontakta:
Gabriel Bennet, finansdirektör                   +41 798 263 713
Patrik Linzenbold, IR-chef                         +46 765 42 27 09
Siobhán Duffy, RBS                                  +44 7788 426 433
[HUG#1405872]
PDF:
http://hugin.info/134730/R/1405872/359499.pdf
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.